Showing results (21-30 of 12,389) with videos related to

Sort By:
Pageof 1,239
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2022
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancerJ M van Berge Henegouwen, M Jebbink, L R Hoes, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2022
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancerSandra M Swain, Antoinette R Tan, Luca Gianni, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literatureHiroki Osumi, Loredana Vecchione, Ulrich Keilholz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatmentsYasuhiro Shirakawa, Hiroshi Tazawa, Shunsuke Tanabe, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trialSomnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Metabolic switch in cancer - Survival of the fittestHans Raskov, Shruti Gaggar, Asma Tajik, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancerChristian D Fankhauser, Matthew G Parry, Adnan Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2022
The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?Barliz Waissengrin, Yasmin Leshem, Marwa Taya, et al.
Pageof 1,239